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Abstract
Objective:   The goal of this study was to examine the association between ECG repolarization 
parameters  and  mortality  in  Chagas  disease  (CD)  patients  living  in  the  United  States.  
Methods: CD patients with cardiomyopathy (CM) and bundle branch block (BBB) or BBB 
alone were compared to age- and sex-matched controls.  QT interval, QT dispersion (QTd), T 
wave peak to T wave end duration (Tp-Te) and T wave peak to T wave end dispersion ((Tp-
Te)d) were measured.  Presence of fractionated QRS (fQRS) was also assessed.  The main 
outcome measure was the association  between ECG parameters  and mortality  or  need for 
cardiac  transplant.                                       
Results: A total of 18 CM and 13 BBB CD patients were studied with 97% originating from 
Mexico  or  Central  America.  QTd  (60.0±15.0  ms  vs  43.5±9.8  ms,  P=0.0002),  Tp-Te 
(102.6±29.3 ms vs  77.1±11.0 ms,  P=0.0002) and (Tp-Te)d  (39.5±9.4 ms vs  22.7±7.6 ms, 
P<0.0001) were prolonged in CD CM patients compared to CM controls.  Chagas CM patients 
had more fQRS then controls (84.2±0.10% vs 33.3±0.11%, p=0.0005).  QTd (59.9±15.0 ms vs 
29.5±6.9 ms, P=0.0001) and (Tp-Te)d (40.0±15.9 ms vs 18.5±5.4 ms, p<0.0001) were longer 
in  the  CD  BBB  group  compared  to  BBB  controls.  Univariate  analysis  showed  QTd 
(56.9±15.0 ms vs 46.5±17.3 ms, p=0.0412) and (Tp-Te)d (36.8±13.5 ms vs 28.5±13.3 ms, 
p=0.0395) were associated with death and/or need for cardiac transplant.                   
Conclusion: CD  patients  with  CM  and  BBB or  BBB alone  have  increased  evidence  of 
dispersion of repolarization compared to controls. QTd and (Tp-Te)d were associated with 
increased  mortality  and/or  need  for  transplant.                                     
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Introduction
Sudden cardiac death (SCD) is the most common cause of mortality in Chagas disease (CD) 
patients from South America and CD patients with cardiomyopathy (CM) are known to have a 
higher mortality than patients with non-ischemic cardiomyopathy (NICM) not related to CD.
[1] Further, CD patients, even without CM, living in South America with cardiac involvement 
are  at  increased  risk  for  SCD.[2]  SCD  is  estimated  to  be  the  cause  of  mortality  in 
approximately 47.6% of all CD patient deaths.[3] Repolarization parameters have been shown 
to be associated with this increased mortality [4] in a South American population.            
However, less is known about SCD risk and clinical outcomes for CD patients living in the 
United States (US).[5] Numerous vectors for the transmission of CD exist in the US, but very 
few cases of autochthonous transmission within the country have been documented [6] and the 
majority  of  patients  with  CD  in  the  US  contracted  the  disease  while  living  in  endemic 
countries prior to immigration to the US.[7]                                             
One reason this population living in the US requires further study is that much of previous 
research on Chagas heart disease involves patients from the Southern Cone region of South 
America where the T Cruzi II strain predominates.[8]  However, the majority of patients in the 
US are immigrants from Mexico and Central America, where T. Cruzi I strain is primarily 
found.[9-12]  There is limited clinical data on risk stratification of this subset of CD patients.  
It is possible that strain differences between regions may lead to differences in the severity of 
cardiac  involvement  and variability  in  SCD risk.[8,13,14]                               
 
New and important clinical data is beginning to emerge regarding CD patients living in the 
US. Recent data from our institution suggests that the prevalence of CD in areas with large 
Latin  American  immigrant  populations  is  higher  than  expected  in  a  community  screening 
program at 1% [15],  while the prevalence was 5.3% [16] when patients from endemic regions 
with bundle branch block (BBB) are screened and 19% in the CM patient population from 
endemic  regions  [16].   In  addition  our  group has  recently  presented  data  that  the  overall 
mortality is higher in the CD CM population (13.4%) than in NICM patients (2.9%) with other 
etiologies  of  CM.[17]                                                 
In the current study we evaluated depolarization and repolarization parameters in a population 
of CD patients with CM (CD-CM) and BBB (CD-BBB) from endemic regions cared for at our 
institution.  We compared these patients to a group of age- and sex-matched control patients 
from endemic regions without CD who have CM (control-CM) and/or BBB (control-BBB), 
and assessed the relationship of these parameters to death or need for cardiac transplant.  
Methods
All CD patients with CM and BBB (n = 18) or BBB alone with a preserved ejection fraction 
(EF) (n = 13) followed at the Olive View-UCLA Center of Excellence for the Treatment of 
CD with at least one year of available follow-up were included.  BBB was defined as right 
bundle branch block (RBBB) and/or  left  anterior  fascicular  block (LAFB).  Age-  and sex-
matched controls  were obtained in  a  1:1 ratio.  The controls  were taken from a  group of 
patients born in endemic CD regions who had similar findings of CM and/or BBB and were 
screened for CD but found to have negative titers.  CD positivity was verified with testing 
utilizing  immumofluorescent  assays and enzyme-linked immunosorbent  assays through the 
Centers for Disease Control and Prevention.  All patients labeled as having CM secondary to 
CD were previously found to have no significant  coronary artery disease (CAD) based on 
previous  coronary  angiography  or  stress  testing  and  had  no  history  consistent  with  an 
alternative  etiology  for  NICM.                                                
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Standard  12-lead  ECGs  were  reviewed  by  two  physicians  blinded  to  patient  groups  and 
classified based on the presence or absence of a fractionated QRS (fQRS) on resting ECG.  
Fractionation was determined based on the work of Das and colleagues [18-20] and defined as: 
1) notching in the nadir of the R or S wave or >1 R' in two contiguous leads in a coronary 
artery territory distribution for a narrow QRS complex; or 2) in the setting of BBB >2 notches 
were required in the R wave or S wave; or 3) for a PVC beat >2 peaks or notches were 
required in 2 contiguous leads or two notches in the R wave greater than 40 ms apart.        
Repolarization parameters including QT interval,  QT dispersion (QTd), T wave peak to T 
wave end  duration  (Tp-Te)  and T wave peak  to  T wave end dispersion  ((Tp-Te)d)  were 
measured  using  electronic  calipers  (Philips  TraceMasterVue  ECG  Management  System, 
Philips  Healthcare,  Andover,  MA)  in  each  patient.  QT  interval  was  measured  from  the 
beginning  of  the  QRS complex  to  the  end  of  the  T wave,  defined  as  the  tangent  to  the 
downslope of  the T wave and the isoelectric  line.[21]  QTd was defined as the difference 
between the maximum and minimum QT interval on all  12-leads of the ECG.  Tp-Te was 
obtained from the difference between the QT interval and the QT peak interval, which was 
measured from the beginning of the QRS to the peak of the T wave.  For a negative or biphasic 
T wave, the QT peak was measured to the nadir of the T wave.  (Tp-Te)d was obtained by the 
difference between the maximum and minimum Tp-Te interval in the precordial leads.[21]   
Follow-up data and mortality rates were based on review of electronic medical records, direct 
phone call follow-up with patients and/or available family contacts and review of the social 
security  database.  Findings  in  the  CD-CM  and  CD-BBB were  compared  to  the  matched 
controls  and  to  each  other.                                                        
Statistical  analysis                                               
Continuous variables are expressed as mean ± SD. Statistical significance was assessed using 
one  way analysis  of  variance  after  examining  normal  quantile  plots  to  determine  that  the 
values followed the normal distribution.  Categorical variables, expressed as frequencies and 
percentages, were compared using Fisher's exact test.  No adjustments were made for multiple 
comparisons, as this is an exploratory study.                                                     
Results
There was no significant difference in baseline characteristics between CD-CM or CD-BBB 
groups and their age/sex matched controls.  (Table 1)  Mean age (years) in the CD-CM group 
was 61±14 vs 62±13 in the control-CM group (p=0.8428) and mean age in the CD-BBB group 
was 50±11 vs 50±11 in the control-BBB group (p=1.0).  Patients had similar  baseline left 
ventricular  EF  (CD-CM  24.5±8.6  %  vs  control-CM  27.7±10.0  %,  p=0.3106;  CD-BBB 
59.8±5.2 % vs control-BBB 59.2±4.9 %, p=0.7647).  Ninety-seven percent of the patients in 
the  CD  and  control  groups  were  from  Mexico  or  Central  America,  with  the  largest 
representation from Central America originating from El Salvador and Guatemala. One patient 
each in the CD-BBB and control-BBB group were from South America (Argentina and Peru 
respectively).  A similar  percentage  of  patients  were on appropriate  CM medications  (beta 
blockers  and  angiotensin-converting  enzyme  inhibitors/angiotensin  receptor  blockers)  that 
have the potential to affect mortality.  In addition similar numbers of patients in the CD and 
control groups had implantable cardioverter-defibrillators (ICDs) in place.  QRS duration was 
similar between the BBB groups (120±25 ms in the CD-BBB vs 116±24 ms in the control-
BBB) and the CM groups (130±31 ms in the CD-CM vs 139±36 ms in the control-CM).  
There was no difference in the use of amiodarone between the BBB groups (1/13 (8%) in CD-
BBB vs 0/13(0%) in control-BBB, p=1.0).  There was a trend toward increased amiodarone 
use in the CD-CM group [5/18 (28%) vs 1/18 (6%)] compared to the control-CM group, but it 
did not reach statistical  significance (p=0.18).  The average follow-up was similar between 
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groups [1976±748 days in the CD patients (1933±254 days in CD-BBB; 2015±1028 days in 
CD-CM) vs 1890±846 days in the control groups (1826±636 days in control-BBB; 1938±875 
days in control-CM), p=0.7822].
Table 1
 
When comparing the CD-CM with the CD-BBB groups there was a significant difference in age 
with CD-CM patients being older  (60.8±14.1 years vs 49.8±11.4 years, p=0.019).  As expected 
the CD-CM patients had a lower left ventricular EF (24.5±8.6 % vs 59.8±5.2 %, p=0.0001).  More 
fractionation of the QRS was seen in the CD-CM group than the CD-BBB group (84.2% vs 
53.8%, p=0.00012).  However, there was no significant difference in QT, QTd, Tp-Te or (Tp-
Te)d.  
CD-CM  patients  had  more  fQRS  than  control-CM  patients  (84.2±0.10%  vs  33.3±0.11%, 
p=0.0005).  The CD-CM QT (424.2±104.1 ms vs 433.72±38.4 ms, p=0.66) was not statistically 
different  than  controls,  however  the  QTd (60.0±15.0  ms  vs  43.5±9.8  ms,  P=0.0002),  Tp-Te 
(102.6±29.3  ms  vs  77.1±11.0  ms,  P=0.0002)  and  (Tp-Te)d  (39.5±9.4  ms  vs  22.7±7.6  ms, 
P<0.0001) were prolonged compared to controls.  (Table 2)
Table 2
CD-BBB patients had prolonged QTd (59.9±15.0 ms vs 29.5±6.9 ms, P=0.0001) and (Tp-Te)d 
(40.0±15.9 ms vs 18.5±5.4 ms, p<0.0001) compared to control-BBB patients.  (Table 2)  In 
addition, CD-BBB patients were found to have increased QTd (59.9±15.0 ms vs 43.5±9.8 ms, 
P=0.0006), Tp-Te (98.7±18.9 ms vs 77.1±11.0 ms, P=0.004) and (Tp-Te)d (40.0±15.9 ms vs 
22.7±7.6 ms, P=<0.0001) compared to the control-CM patients.                                 
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At the time  of  analysis,  after  a  mean follow-up of  1976±748 days  in  the  CD patients  vs 
1890±846 days in the control groups (p=0.7822), 11 patients with CD (10 CM and 1 BBB) 
had died and 1 received a cardiac transplant.  Three patients in the control-CM and no control-
BBB group patients had died.  The mortality was significantly higher in the CD-CM group 
compared to the CM-control group (56% vs 17%, p=0.022) Univariate analysis demonstrated 
that QTd (56.9±15.0 ms vs 46.5±17.3 ms, p=0.0412), (Tp-Te)d (36.8±13.5 ms vs 28.5±13.3 
ms, p=0.0395) and left ventricular EF (26±13% vs 44±17%, p=0.001) were associated with 
death  or  transplant.  (Figure  1)                                          
Figure 1: Jitter-plot of QTd measurement comparing surviving patients to those that died or underwent cardiac 
transplant.  ms=  milliseconds,  tx=transplant.                                          
Discussion
CD, caused by the protozoan Trypanosoma Cruzi (T. Cruzi) was previously estimated by the 
World Health  Organization  to  affect  some 16-18 million  people  throughout  the  American 
continent [22], including over 300,000 people in the US based on a 2009 estimate.[23] The 
worldwide estimate has decreased in recent years due to public health initiatives with a recent 
estimate  of  approximately  8  million  infected  people.[24]  However,  while  public  health 
initiatives in Southern and Central America have decreased the incidence of new infections 
[25],  CD  remains  a  significant  cause  of  cardiac  morbidity  and  mortality.            
Heart disease is the most frequent clinical manifestation of CD, affecting approximately 30% 
of infected individuals after twenty years of initial exposure. [2,26] Chagas heart disease is 
characterized by cardiomegaly,  congestive heart  failure,  and rhythm disturbances including 
conduction system disease,  ventricular  arrhythmias,  and SCD.[2,27,28]  Conduction system 
disturbances, most commonly RBBB and LAFB precede the development of CM by many 
years.  However there appears to be a significantly increased mortality in this population even 
prior  to  the  development  of  CM.[2]                                      
 
The  increased  SCD rate  in  the  CD population  has  not  been  completely  explained  in  the 
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literature.  In addition to the structural  abnormalities  in  the CM population there is  also a 
potential  autonomic component due to destruction of parasympathetic innervation [29] that 
may lead to a mismatch of sympathetic and parasympathetic stimulation.                                 
It  is  known in  the  non-CD population  that  increased  sympathetic  cardiac  stimulation  can 
increase  the  risk  of  malignant  ventricular  arrhythmias.[30,31]  One  mechanism  that  may 
contribute to this increased risk is more pronounced dispersion of repolarization and risk for 
induction  of  reentrant  ventricular  arrhythmias.  Recent  studies  have  shown  that  neuraxial 
modulation via thoracic epidural anesthesia or surgical left cardiac sympathetic denervation 
can significantly decrease arrhythmia burden in a non-CD CM population.[32] However, this 
potential contribution to, and intervention for, SCD has not been proven in the CD population.
[29]
   
The use of surface 12-lead ECG intervals as surrogate evidence of dispersion of repolarization 
to predict risk of SCD dates back to the work of Schwartz and colleagues.[33] QTd has been 
studied extensively and been shown to be a marker of risk for ventricular arrhythmias after 
myocardial infarction [34] and in patient with depressed left ventricular EFs [35].  QTd has 
been evaluated as a risk marker in CD as well and is an independent predictor of all-cause 
death  and  arrhythmic  death  in  CD  patients  in  South  America.[4]  Other  repolarization 
parameters  such  as  Tp-Te  and  (Tp-Te)d  have  been  studied  in  other  populations  such  as 
hypertrophic  cardiomyopathy  [36]  and  Brugada  syndrome  [21]  with  evidence  that  these 
parameters  may  be  a  better  predictor  than  QTd  for  inducible  ventricular  arrhythmias, 
spontaneous ventricular  arrhythmias,  need for appropriate  ICD therapy [37] and SCD.[38]  
The  depolarization  parameter,  fragmented  QRS  (fQRS),  is  a  known  marker  of  increased 
mortality in CAD [19] and a marker of increased arrhythmic events in CAD, ischemic CM and 
NICM [39,40] as well as Brugada syndrome [41], but has not been previously studied in a CD 
population.  These parameters need further data in CD.                                    
In this study, CD patients living in the US with CM and BBB or BBB with preserved EF have 
increased evidence of dispersion of repolarization measured by QTd and (Tp-Te)d compared 
to  age-  and sex-matched  controls  from endemic  regions.  CD-CM patients  could  only  be 
differentiated  from CD-BBB patients  based  on  increased  frequency  of  fQRS,  but  not  on 
repolarization parameters.  The increased QTd and (Tp-Te)d was associated  with increased 
mortality  and/or  need  for  transplant.  These  findings  may  give  insight  into  the  increased 
mortality  risk  in  this  patient  population.                                          
Interestingly, there was no difference in QTd or (Tp-Te)d between the CD-CM and CD-BBB 
group suggesting that the pathologic changes that may predispose to ventricular arrhythmias 
and SCD may precede the development of frank left ventricular dysfunction.  Further data is 
needed to determine  if  CD patients  with BBB, but  without  CM, originating  from Central 
America  and  Mexico  have  a  significant  mortality  risk  that  suggest  the  need  for  more 
aggressive intervention such as ICD implantation prior to the development of a depressed EF.
Further, CD-BBB patients had more significant QTd and (Tp-Te)d than the control-CM group. 
This may call  into question the current guidelines which advocate specific therapies based 
predominantly on discrete EF criteria.  The current criteria may not accurately predict risk in 
the  CD  patient  population.                                                 
Limitations
The limited sample size of our study makes multivariate analysis impossible which limits the 
interpretability of the study.  Conclusions based on associations of mortality are also limited 
by the  lack  of  documented  evidence  of  SCD as  the etiology of  death.                   
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Similar  repolarization  parameters  were  found  when  comparing  CD-CM  and  CD-BBB 
patients.  The  majority  of  deaths  occurred  in  the  CD-CM  group  however.  Therefore,  an 
argument can be made that repolarization abnormalities alone are not sufficient to increase the 
risk of death in the CD population.  However, the number and length of follow-up of CD-BBB 
patients was limited and therefore further data is needed.                                      
Conclusion
Over 20 years has passed since the first publication on Chagas heart disease in the US by 
Hagar and Ramtoola in 1991 [5] with limited assessment of this patient population over that 
timespan.  This is to date the largest study of chagas heart disease patients in the US and the 
only study on a US population assessing predictors of mortality.  QTd and (Tp-Te)d were 
prolonged in CD-CM and CD-BBB patients compared to controls.  Measures of dispersion 
were also significantly prolonged in the CD-BBB in comparison to CM controls.  Univariate 
analysis demonstrated that QTd and (Tp-T)d were associated with death or transplant in the 
CD population.  Further data  is  needed to assess the significance of these findings and to 
determine if region of origin and strain of T. cruzi infection affect clinical outcomes.      
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